End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
9.1 DKK | -8.82% | -9.45% | -48.73% |
Apr. 16 | Curasight A/S Announces Approval of Clinical Trial Application for Phase 2 Trial with uTRACE in Prostate Cancer Patients | CI |
Apr. 12 | Curasight A/S Announces Board Changes | CI |
Chart calendar Curasight A/S
Upcoming events on Curasight A/S
Past events on Curasight A/S
2024-03-21 05:00 am | Annual General Meeting |
2024-02-21 | Q4 2023 Earnings Release |
2023-11-23 01:00 am | Q3 2023 Earnings Release |
2023-08-31 05:30 am | HC Andersen Capital Life Science Seminar |
2023-08-23 | Q2 2023 Earnings Release |
2023-05-31 07:30 am | Økonomisk Ugebrev Life Science Investor Conference |
2023-05-31 04:30 am | HC Andersen Capital Presentation |
2023-05-25 01:32 am | Q1 2023 Earnings Release |
2023-03-30 04:00 am | Annual General Meeting |
2023-02-27 08:00 am | Q4 2022 Earnings Call |
2023-02-23 01:00 am | FY 2022 Earnings Release |
2023-01-19 12:00 am | Redeye Fight Cancer Seminar |
2023-01-08 | SEB Nordic Seminar |
2022-11-28 06:00 am | Q3 2022 Earnings Call |
2022-11-23 | Q3 2022 Earnings Release |
2022-11-21 07:05 am | SEB Healthcare Seminar |
2022-08-23 | Interim 2022 Earnings Release |
2022-05-24 01:00 am | Q1 2022 Earnings Release |
2022-05-18 05:00 am | Kapital Partners Life Science Seminar |
2022-04-27 04:00 am | Annual General Meeting |
Annual results
Fiscal Period | December | 2022 | 2023 | 2024 |
---|---|---|---|---|
Net sales Million DKK | Released Forecast Spread | 0,00 | 0,00 0,00 - | 0,00 |
EBITDA Million DKK | Released Forecast Spread | 0,00 | -32,1 -26,0 -23.55% | -64,0 |
EBIT Million DKK | Released Forecast Spread | 0,00 | -33,2 -26,0 -27.75% | -64,0 |
Earnings before Tax (EBT) Million DKK | Released Forecast Spread | -19,5 | 0,00 0,00 - | 0,00 |
Net income Million DKK | Released Forecast Spread | -18,3 | 0,00 0,00 - | 0,00 |
EPS | Released Forecast Spread | 0,00 | 0,00 0,00 - | 0,00 |
Announcement Date | 23/02/23 | 22/02/24 | - |
Today 04:05 pm | QIAGEN N.V.: Q1 2024 Earnings Release |
2024-04-29 | CRISPR THERAPEUTICS AG: Q1 2024 Earnings Release (Projected) |
2024-04-30 | DYNE THERAPEUTICS, INC.: Q1 2024 Earnings Release (Projected) |
2024-04-30 | PROTAGONIST THERAPEUTICS, INC.: Q1 2024 Earnings Release (Projected) |
2024-04-30 | EDITAS MEDICINE, INC.: Q1 2024 Earnings Release (Projected) |
2024-04-30 | AZENTA, INC.: Q2 2024 Earnings Release (Projected) |
2024-05-01 06:30 am | UNITED THERAPEUTICS CORPORATION: Q1 2024 Earnings Release |
2024-05-01 06:30 am | BIO-TECHNE CORPORATION: Q3 2024 Earnings Release |
2024-05-01 07:00 am | ALKERMES PLC: Q1 2024 Earnings Release |
2024-05-01 | VIR BIOTECHNOLOGY, INC.: Q1 2024 Earnings Release |
Past sector events for Curasight A/S
Net sales - Annual - Rate of surprise
- Stock Market
- Equities
- CURAS Stock
- Calendar Curasight A/S